Shots:
Given the high variability and subjectivity of traditional clinical scales, there is an urgent need for objective biomarkers to assess CNS disease progression more reliably
NeuraLight is at the forefront of precision neurology, developing objective and sensitive biomarkers that bring greater accuracy and consistency to CNS research
In this exclusive conversation, Edmund…
In the CXO Talks podcast, PharmaShots spoke with Ali Jannati, Director of Cognitive Science at Linus Health. Ali eloquently highlighted Linus’ journey to becoming a leader in digital brain health through its innovative digital cognitive assessment platform
He emphasized the importance of digital biomarkers in evaluating brain function by capturing subtle nuances and response latencies,…
For the December Edition, PharmaShots magazine navigated Digital Biomarkers as a theme. Digital biomarkers are physiological and behavioral data gathered by wearables, ingestible devices, and implants.
By harnessing and assessing digital biomarkers, healthcare researchers can predict the early onset of diseases, check disease progressions, and study lifestyle’s impact on health in general.
Our curated sections…
Shots:
Marisa Cruz, MD, and Chief Medical Officer at Empatica, exchanged thoughts with PharmaShots on the revolutionary Empatica Health Monitoring Platform (EHMP)
Approved by the FDA in Nov’2022, EHMP leverages a cloud-based online portal to collect continuous and seamless physiological data from home and clinical setting
While conversing in great depth about Empatica’s EmbracePlus smartwatch,…
The Healthcare industry is going through a technological revolution and it is vital for the industry to work on new technologies that will help to generate, collect & track novel data. The availability of large data makes the system becomes important to convert it into appropriate information which will helps industry researchers, clinicians, doctors, entrepreneurs,…

